KCM
AMAG

Kennedy Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Kennedy Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-201,441
Closed -$2.6M – 750
2019
Q1 		$2.6M Buy
201,441
+393
+0.2% +$5.85K 0.06% 492
2018
Q4 		$3.05M Buy
+201,048
New +$3.83M 0.08% 456
2017
Q1 		– Sell
-75,201
Closed -$2.62M – 773
2016
Q4 		$2.62M Sell
75,201
-109,125
-59% -$3.26M 0.05% 552
2016
Q3 		$4.52M Buy
+184,326
New +$4.61M 0.09% 393
2016
Q2 		– Sell
-147,551
Closed -$3.45M – 762
2016
Q1 		$3.45M Sell
147,551
-1,980
-1% -$47K 0.07% 463
2015
Q4 		$4.51M Buy
149,531
+90,736
+154% +$2.93M 0.09% 399
2015
Q3 		$2.34M Buy
+58,795
New +$3.65M 0.05% 543
2015
Q2 		– Sell
-25,894
Closed -$1.42M – 766
2015
Q1 		$1.42M Buy
25,894
+18,531
+252% +$883K 0.02% 623
2014
Q4 		$314K Sell
7,363
-14,678
-67% -$530K 0.01% 725
2014
Q3 		$703K Buy
+22,041
New +$470K 0.01% 691
2014
Q1 		– Sell
-282,215
Closed -$6.85M – 794
2013
Q4 		$6.85M Buy
282,215
+24,335
+9% +$572K 0.13% 304
2013
Q3 		$5.54M Sell
257,880
-13,148
-5% -$311K 0.11% 354
2013
Q2 		$6.03M Buy
+271,028
New +$5.97M 0.12% 312

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Kennedy Capital Management's AMAG Position: Q2 2019 in Review

Kennedy Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2019, closing a stake of 201,441 shares — an estimated $2.6M sold.

Kennedy Capital Management first reported a position in AMAG in Q2 2013 and held it in 13 quarters. The position peaked at $6.85M in Q4 2013. 170 funds tracked by Wall St. Rank hold AMAG as of Q2 2019.

  • Kennedy Capital Management reported no remaining AMAG Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Kennedy Capital Management sold 201,441 AMAG Pharmaceuticals shares in Q2 2019, an estimated $2.6M.
  • Kennedy Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • Kennedy Capital Management's AMAG Pharmaceuticals position peaked at $6.85M in Q4 2013.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2019.

Based on Kennedy Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.